Every_DT
enhancer_NN
works_NNS
with_IN
every_DT
promoter_NN
for_IN
all_PDT
the_DT
combinations_NNS
tested_VBN
:_:
could_MD
new_JJ
regulatory_JJ
pathways_NNS
evolve_VBP
by_IN
enhancer_NN
shuffling_NN
?_.

The_DT
promoters_NNS
and_CC
enhancers_NNS
of_IN
cell_NN
type-specific_JJ
genes_NNS
are_VBP
often_RB
conserved_VBN
in_IN
evolution_NN
,_,
and_CC
hence_RB
one_PRP
might_MD
expect_VB
that_IN
a_DT
given_JJ
enhancer_NN
has_VBZ
evolved_VBN
to_TO
work_VB
best_RBS
with_IN
its_PRP$
own_JJ
promoter_NN
._.

While_IN
this_DT
expectation_NN
may_MD
be_VB
realized_VBN
in_IN
some_DT
cases_NNS
,_,
we_PRP
have_VBP
not_RB
found_VBN
evidence_NN
for_IN
it_PRP
._.

A_DT
total_NN
of_IN
27_CD
combinations_NNS
of_IN
different_JJ
promoters_NNS
and_CC
enhancers_NNS
were_VBD
tested_VBN
by_IN
transfection_NN
into_IN
cultured_VBN
cells_NNS
._.

We_PRP
found_VBD
that_IN
the_DT
relative_JJ
efficiency_NN
of_IN
the_DT
enhancers_NNS
is_VBZ
approximately_RB
the_DT
same_JJ
,_,
irrespective_JJ
of_IN
the_DT
type_NN
of_IN
promoter_NN
used_VBN
,_,
i.e._FW
,_,
there_EX
was_VBD
no_DT
strong_JJ
preference_NN
for_IN
any_DT
given_JJ
enhancer\/promoter_NN
combination_NN
._.

Notably_RB
,_,
we_PRP
do_VBP
not_RB
see_VB
particularly_RB
strong_JJ
transcription_NN
when_WRB
the_DT
immunoglobulin_NN
kappa_NN
enhancer_NN
-LRB-_-LRB-
or_CC
the_DT
immunoglobulin_NN
heavy_JJ
chain_NN
enhancer_NN
-RRB-_-RRB-
is_VBZ
used_VBN
to_TO
activate_VB
a_DT
kappa_NN
gene_NN
promoter_NN
._.

We_PRP
propose_VBP
that_IN
a_DT
generally_RB
permissive_JJ
enhancer\/promoter_NN
interaction_NN
is_VBZ
of_IN
evolutionary_JJ
benefit_NN
for_IN
higher_JJR
eukaryotes_NNS
:_:
by_IN
enhancer_NN
shuffling_NN
,_,
genes_NNS
could_MD
be_VB
easily_RB
brought_VBN
under_IN
a_DT
new_JJ
type_NN
of_IN
inducibility\/cell_NN
type_NN
specificity_NN
._.

